Here, we assume that higher expression in more advanced stages, higher grades, multifocal disease, lymph node metastasis-positive samples, and Ki-67-positive samples represents an unfavorable, pro-cancerous (oncogenic) factor, whereas lower expression under these conditions may indicate tumor suppressor roles. Here, MKI67 is linked to metastatic malignant neoplasm in the lymph nodes.